Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McDermott

Showing results (531-540 of 541) with videos related to

Pageof 55
Sort By:
The Journal of Pain|December 18, 2019
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT RecommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|March 9, 2010
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pain|April 13, 2012
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Contemporary Clinical Trials|April 29, 2017
Developing standardized corticosteroid treatment for Duchenne muscular dystrophyMichela Guglieri, Kate Bushby, Michael P McDermott, et al.
Neuromuscular Disorders : NMD|May 26, 2022
Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophyAnna G Mayhew, Dionne Moat, Michael P McDermott, et al.
Trials|May 26, 2018
A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trialRebecca A Crow, Kimberly A Hart, Michael P McDermott, et al.
Nature Biotechnology|February 2, 2016
Haplotyping germline and cancer genomes with high-throughput linked-read sequencingGrace X Y Zheng, Billy T Lau, Michael Schnall-Levin, et al.
Pageof 55

Showing results (531-540 of 541) with videos related to

Sort By:
Pageof 55
The Journal of Pain|December 18, 2019
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT RecommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|March 9, 2010
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pain|April 13, 2012
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Contemporary Clinical Trials|April 29, 2017
Developing standardized corticosteroid treatment for Duchenne muscular dystrophyMichela Guglieri, Kate Bushby, Michael P McDermott, et al.
Neuromuscular Disorders : NMD|May 26, 2022
Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophyAnna G Mayhew, Dionne Moat, Michael P McDermott, et al.
Trials|May 26, 2018
A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trialRebecca A Crow, Kimberly A Hart, Michael P McDermott, et al.
Nature Biotechnology|February 2, 2016
Haplotyping germline and cancer genomes with high-throughput linked-read sequencingGrace X Y Zheng, Billy T Lau, Michael Schnall-Levin, et al.
Pageof 55